JW Pharmaceutical to buy Solidus Investment for KRW 30.728 billion, taking 100% stake
JW Pharmaceutical said its board approved Sept. 29, 2026 acquisition of all Solidus Investment shares by buying 2,000,000 shares for KRW 30.728 billion in cash.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.